ECM
KPRX icon

ExodusPoint Capital Management’s Kiora Pharmaceuticals KPRX Stock Holding History

ExodusPoint Capital Management’s Portfolio KPRX Stock Details KPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-35
Closed -$62K – 2589
2021
Q1 		$62K Buy
+35
New +$76.3K ﹤0.01% 2015

Other funds holding KPRX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return

ExodusPoint Capital Management's KPRX Position: Q2 2021 in Review

ExodusPoint Capital Management sold out of Kiora Pharmaceuticals (KPRX) in Q2 2021, closing a stake of 35 shares — an estimated $62K sold.

ExodusPoint Capital Management first reported a position in KPRX in Q1 2021 and held it in 1 quarter. The position peaked at $62K in Q1 2021. 17 funds tracked by Wall St. Rank hold KPRX as of Q2 2021.

  • ExodusPoint Capital Management reported no remaining Kiora Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • ExodusPoint Capital Management sold 35 Kiora Pharmaceuticals shares in Q2 2021, an estimated $62K.
  • ExodusPoint Capital Management first reported a position in Kiora Pharmaceuticals in Q1 2021 and held it in 1 quarter.
  • ExodusPoint Capital Management's Kiora Pharmaceuticals position peaked at $62K in Q1 2021.
  • 17 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q2 2021.

Based on ExodusPoint Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.